Citius Oncology Inc (CTOR)
1.20
+0.17
(+16.98%)
USD |
NASDAQ |
Nov 05, 16:00
1.18
-0.02
(-1.67%)
After-Hours: 18:25
Citius Oncology Net Income (Annual)
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
September 30, 2023 | -12.70M |
Date | Value |
---|---|
September 30, 2022 | -5.433M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-12.70M
Minimum
2023
-5.433M
Maximum
2022
-9.065M
Average
-9.065M
Median
Net Income (Annual) Benchmarks
Citius Pharmaceuticals Inc | -32.54M |
NovaBay Pharmaceuticals Inc | -9.64M |
Palatin Technologies Inc | -29.74M |
iBio Inc | -24.91M |
Theriva Biologics Inc | -18.35M |